This track explores the evolving EU regulatory and market access landscape, focusing on practical guidance for Joint Clinical Assessments, harmonized health indicators, and reducing hidden treatment costs. Participants will gain actionable insights to optimize processes, engage with authorities, and improve outcomes for patients across Europe.